Table 1 Patient backgrounds before and after propensity score matching
Before matching | After matching | |||||||
|---|---|---|---|---|---|---|---|---|
PCU care (n = 276) | Discharge-to-home (n = 167) | P-value | Standardized difference | PCU care (n = 128) | Discharge -to-home (n = 128) | P-value | Standardized difference | |
Age (in years), mean (SD) | 72.96 (10.68) | 73.46 (11.26) | 0.637 | 0.046 | 73.96 (10.45) | 73.50 (11.49) | 0.737 | 0.042 |
Sex (male/female) | 161/115 | 92/75 | 0.504 | 0.065 | 74/54 | 69/59 | 0.529 | 0.079 |
PPI at admission, mean (SD) | 6.2 (3.22) | 3.50 (2.77) | < 0.001 | 0.902 | 4.20 (2.70) | 4.19 (2.70) | 0.982 | 0.004 |
Hepatobiliary pancreatic cancer | 50 (18.1%) | 25 (15.0%) | 0.392 | 0.083 | 23 (18.0%) | 18 (14.1%) | 0.394 | 0.10 |
Respiratory cancer | 75 (27.2%) | 41 (24.6%) | 0.543 | 0.059 | 28 (21.9%) | 31 (24.2%) | 0.656 | 0.055 |
Gastrointestinal cancer | 80 (29.0%) | 41 (24.6%) | 0.310 | 0.099 | 31 (24.2%) | 35 (27.3%) | 0.568 | 0.071 |
Head and neck cancer | 12 (4.3%) | 19 (11.4%) | 0.005 | 0.26 | 11 (8.6%) | 8 (6.3%) | 0.474 | 0.088 |
Urological cancer | 25 (9.1%) | 19 (11.4%) | 0.429 | 0.076 | 19 (14.8%) | 18 (14.1%) | 0.859 | 0.020 |
Skin cancer | 4 (1.4%) | 3 (1.8%) | 0.530 | 0.032 | 1 (0.8%) | 1 (0.8%) | 1.0 | 0 |
Gynecological cancer | 23 (8.3%) | 14 (8.4%) | 0.985 | 0.004 | 13 (10.2%) | 13 (10.2%) | 1.0 | 0 |
Others | 7 (2.5%) | 5 (3.0%) | 0.774 | 0.031 | 2 (1.6%) | 4 (3.1%) | 0.342 | 0.099 |